Welcome to another edition of the Blossom TMS Provider Spotlight series, where we showcase key figures making waves in the TMS industry. Today, we’re excited to sit down with Christian Hirschbeck, our very own CEO at SEBERS Medical. Christian has over 15 years of experience in the field of TMS and neurostimulation, leading…
Welcome to the Blossom Provider Spotlight series, where we highlight outstanding providers in the mental health field. This week, we’re thrilled to feature Dr. Alex Lazar, a highly experienced psychiatrist based in Encino, California. With over two decades of practice in adult and child psychiatry, Dr. Lazar has recently expanded his treatment offerings…
Welcome to our first installment of the “Blossom Provider Spotlight,” where we feature insightful conversations with the exceptional providers using the Blossom TMS device. This week, we had the pleasure of speaking with Nicholas Goodwin, a psychiatric nurse practitioner and the founder of Goodwin Health Cafe in Spokane, Washington. Tell us a little bit about…
Welcome to the Blossom Provider Spotlight series, where we highlight exceptional providers in the mental health field. This week, we’re excited to feature Casey Dubravcic, owner and operator of Revitalize Ketamine Clinic. Based in Flagstaff, Arizona, with additional locations in Sedona and Prescott Valley, Casey and his team are dedicated to offering innovative…
A Primer on Its Physical Principles, Practicalities, Protocols and Evidence Base Authors: Leo Chen and Linda L. Carpenter Excerpt from our magazine: This blog post is an excerpt from our magazine. For a free digital or print version to read the full article and much more, visit us at https://sebersmedical.com/. Introduction Repetitive transcranial magnetic…
Phone: 833.3BUY.TMS (+1.833.3289.867)
Email: Sales@sebersmedical.com
Address: 230 S Broad Street, 17th Floor Philadelphia, PA 19102
Regulations in the United States
*United States Federal Law regulates the sale of Medical Devices. The Blossom TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. (K220625) All other devices on this website are not approved and/or cleared for use in treatment and/or diagnosis in the United States. All investigational devices must be labeled in accordance with the labeling requirements of the IDE regulation (§ 812.5) and bear a label that states:
“CAUTION.
Investigational Device. Restricted by federal (or United States) law to research use.”
© 2024 SEBERS MEDICAL
